Stomach Cancer and Gastric Cancer Treatment Market Insights Video
According to Cognitive Market Research, the global Stomach Cancer and Gastric Cancer Treatment market size is USD 4124.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 13.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1649.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1237.26 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 948.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.2% from 2024 to 2031.
Latin America had a market share for more than 5% of the global revenue with a market size of USD 206.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 82.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.
In 2023, the injectable segment led the gastric cancer therapy market
